Keratoconjunctivitis Sicca
Showing NaN - NaN of 5
Keratoconjunctivitis Sicca, Dry Eye Trial in United States (tavilermide ophthalmic solution, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye
- tavilermide ophthalmic solution
- Placebo
-
Phoenix, Arizona
- +21 more
Oct 18, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Phoenix, Arizona
- +59 more
Jan 19, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121, Placebo)
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121
- Placebo
-
Artesia, California
- +10 more
Jan 4, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Birmingham, Alabama
- +61 more
Dec 10, 2020
Keratoconjunctivitis Sicca, Sjogren's Syndrome, Lupus Erythematosus, Systemic Trial in United States (Ophthalmic Emulsion)
Completed
- Keratoconjunctivitis Sicca
- +4 more
- Ophthalmic Emulsion
-
La Jolla, California
- +16 more
May 27, 2011